Versant Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91K | Sell |
358
-415
| -54% | -$3.38K | ﹤0.01% | 2310 |
|
|
2025
Q1 | $6.07K | Buy |
773
+525
| +212% | +$4.12K | ﹤0.01% | 1960 |
|
|
2024
Q4 | $3.69K | Buy |
248
+9
| +4% | +$134 | ﹤0.01% | 1900 |
|
|
2024
Q3 | $3.65K | Buy |
239
+100
| +72% | +$1.53K | ﹤0.01% | 1384 |
|
|
2024
Q2 | $2.12K | Buy |
+139
| New | +$2.12K | ﹤0.01% | 1494 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$207 | – | 1799 |
|
|
2022
Q4 | $207 | Sell |
10
-2
| -17% | -$41 | ﹤0.01% | 1597 |
|
|
2022
Q3 | $0 | Sell |
12
-1
| -8% | – | ﹤0.01% | 1613 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1611 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 1594 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1330 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 1564 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1572 |
|
|
2021
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 1588 |
|
|
2020
Q4 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1497 |
|